Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tracing a new Drug's journey through the body

NCT ID NCT07712718

Recruiting now Knowledge-focused Sponsor: Mirum Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This early-stage trial tracks how the experimental drug MRM-3379 moves through the body and is eliminated. Eight healthy men receive a single oral dose of a specially labeled version of the drug. Researchers measure radioactivity in blood, urine, and feces to understand absorption, distribution, metabolism, and excretion.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a radiolabeled form of the experimental drug MRM-3379
What this could lead to
This study will help determine how MRM-3379 is processed by the body, which is essential for planning future trials in people with liver disease.
What could go wrong
This is a very early, small study in just 8 healthy men, so results may not predict how the drug works in patients or in women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Fortrea Clinical Research Unit Inc

    RECRUITING

    Madison, Wisconsin, 53704, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.